223 related articles for article (PubMed ID: 20085962)
1. A review of pharmacologic options for previously untreated chronic lymphocytic leukemia.
Wilhelm K; Yang D
J Oncol Pharm Pract; 2011 Jun; 17(2):91-103. PubMed ID: 20085962
[TBL] [Abstract][Full Text] [Related]
2. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
Abbott BL
Clin Adv Hematol Oncol; 2004 Jul; 2(7):448-54. PubMed ID: 16163221
[TBL] [Abstract][Full Text] [Related]
3. Treatment options for newly diagnosed patients with chronic lymphocytic leukemia.
Erba HP
Curr Hematol Rep; 2004 Jan; 3(1):47-53. PubMed ID: 14695850
[TBL] [Abstract][Full Text] [Related]
4. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
Robak T; Lech-Maranda E; Robak P
Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic lymphocytic leukemia.
Faderl SJ; Keating MJ
Curr Hematol Rep; 2005 Jan; 4(1):31-8. PubMed ID: 15610657
[TBL] [Abstract][Full Text] [Related]
6. Chemoimmunotherapy of chronic lymphocytic leukemia.
Tam CS; Keating MJ
Best Pract Res Clin Haematol; 2007 Sep; 20(3):479-98. PubMed ID: 17707835
[TBL] [Abstract][Full Text] [Related]
7. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
[TBL] [Abstract][Full Text] [Related]
8. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
Abbott BL
Hematol Oncol; 2005 Mar; 23(1):34-40. PubMed ID: 16149106
[TBL] [Abstract][Full Text] [Related]
9. Controversies in the front-line management of chronic lymphocytic leukemia.
Nabhan C; Shanafelt TD; Kay NE
Leuk Res; 2008 May; 32(5):679-88. PubMed ID: 18191201
[TBL] [Abstract][Full Text] [Related]
10. Management of advanced chronic lymphocytic leukemia.
Cao TM; Coutre SE
Curr Hematol Rep; 2003 Jan; 2(1):65-72. PubMed ID: 12901156
[TBL] [Abstract][Full Text] [Related]
11. Etiology and management of tumor lysis syndrome in patients with chronic lymphocytic leukemia.
Cheson BD
Clin Adv Hematol Oncol; 2009 Apr; 7(4):263-71. PubMed ID: 19521331
[TBL] [Abstract][Full Text] [Related]
12. Chronic lymphocytic leukemia in the elderly population.
Rai KR
Clin Geriatr Med; 1997 May; 13(2):245-9. PubMed ID: 9115449
[TBL] [Abstract][Full Text] [Related]
13. Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.
Dennie TW; Kolesar JM
Clin Ther; 2009; 31 Pt 2():2290-311. PubMed ID: 20110042
[TBL] [Abstract][Full Text] [Related]
14. Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia.
Del Poeta G; Ilaria Del Principe M; Buccisano F; Maurillo L; Niscola P; Venditti A; Amadori S
Expert Rev Anticancer Ther; 2006 Dec; 6(12):1787-800. PubMed ID: 17181492
[TBL] [Abstract][Full Text] [Related]
15. Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia.
Dighiero G; Maloum K; Desablens B; Cazin B; Navarro M; Leblay R; Leporrier M; Jaubert J; Lepeu G; Dreyfus B; Binet JL; Travade P
N Engl J Med; 1998 May; 338(21):1506-14. PubMed ID: 9593789
[TBL] [Abstract][Full Text] [Related]
16. Clinical roundtable monograph. New alternatives in CLL therapy: managing adverse events.
Chanan-Khan A; Kipps T; Stilgenbauer S
Clin Adv Hematol Oncol; 2010 Aug; 8(8):suppl 1-15. PubMed ID: 21192630
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody therapy of chronic lymphocytic leukemia.
Mavromatis B; Cheson BD
J Clin Oncol; 2003 May; 21(9):1874-81. PubMed ID: 12721266
[TBL] [Abstract][Full Text] [Related]
18. Chronic lymphocytic leukaemia: current first-line therapy.
Carney DA; Mulligan SP
Intern Med J; 2009 Jan; 39(1):44-8. PubMed ID: 19290981
[TBL] [Abstract][Full Text] [Related]
19. Management of chronic lymphocytic leukemia.
Han T; Rai KR
Hematol Oncol Clin North Am; 1990 Apr; 4(2):431-45. PubMed ID: 2182600
[TBL] [Abstract][Full Text] [Related]
20. Purine analogue-based chemotherapy regimens for patients with previously untreated B-chronic lymphocytic leukemia.
Kay NE
Semin Hematol; 2006 Apr; 43(2 Suppl 2):S50-4. PubMed ID: 16549115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]